As of 2026-03-30, 辉瑞新冠疫苗's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 0.00%, below the industry average by 1.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 辉瑞新冠疫苗's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
辉瑞新冠疫苗's Mention Rate is 0.00%, lower than 0.6% of competitors
辉瑞新冠疫苗's First Mention is 0.00%, lower than 0.9% of competitors
辉瑞新冠疫苗's Preferred Rate is 0.00%, lower than 100.0% of competitors
辉瑞新冠疫苗's Positive Rate is 0.00%, lower than 8.9% of competitors
辉瑞新冠疫苗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 苯苯磺酸左氨氯地平片 | 4.26% | 0% | 0% | 4.26% | 0% | View Details |
| 信信迪利单抗 | 2.13% | 0% | 0% | 2.13% | 0% | View Details |
| 安安宫牛黄丸 | 0% | 0% | 0% | 0% | 0% | View Details |
| 藿藿香正气水 | 0% | 0% | 0% | 0% | 0% | View Details |
| mmRNA新冠疫苗 | 0% | 0% | 0% | 0% | 0% | View Details |
| 倍倍他乐克 | 0% | 0% | 0% | 0% | 0% | View Details |
| 辉辉瑞新冠疫苗 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
